Shareholders meeting

Mangalam Drugs and Organics Limited Regd. Office : Rupam Building, 3rd F- loor, 239 P. D’i Mello Roaa:d , " NearG. P.0 . Mum m-b 40a0 0i01 “ @gl 22-62616200/ 63/0 87087 @ 91-22-62619090 e CIN : L24230MH1972 PLC116413 REF: MDOL/CS-SE/2026-27/0028 September 2314, 2026 Listing Department Listing Department BSE Ltd 1! Floor, New Trade Wing, National Stock Exchange of India Limited Phiroze Jecjeebhoy Towers, “Exchange Plaza™, 5% Floor, Plot No. C-1, Block G, Dalal Street, Fort, Bandra - Kurla Complex, Mumbai - 400 001. Bandra(E), Mumbai — 400 051 Serip Code: 532637 Symbol: MANGALAM CDS ou rb nuj fge esc r t e: a n n cQ d iu nt O grc (go "am n Ve i C c "/ s )P r L oo i rc m Oe i te t hd e ei dn r g h As e u l do d if oo5 -n3 V i¢ W s e uA adn lnn eu Msa edl aa nyG s,e n (e S "r e Oa p Al t VeM m Me b "e e )t r .i n 2g 3, ( 2A 0G 2M 6_) t ho rf o M uga hn g Va il da em o R Ine df ie ar e (n Lc ie s: iR nge g Ou bl la it gi ao tn o3 n0 r ae na dd Dw ii st ch oS sc uh re ed Rul ee uI iI rT eo mf t nh te )S e Rc eu gr ui lt ai te is oa nn sd 2E 0x 1c 5h ,a nge Board of Dear Sir/ Madam, 4WpW :r ei 0o dt 0c nh e e Pe sr .de Mdis .anp yge (,sc It So Tt e )fo p (tc t iea h nep m t b li e( uo r d5n i3e 2 nd 3) , s t2u hFi 0b efj 2t te 5y ic , t eTTa hh an i e ld r m wGe A en n M dt n i fuo c oan rol e m d -mG ver e oe nn tf e ice r ner gae d ln c tae tM A, e 0 Gep 3 Mtl : )e i 0a n 0 .s g e P .of Mi fn d t ( h Ie e Sn Tc C )l o o as m ne p dd a ch n oe y nr ce lw h ui e dt l eh d dt oh an te We request you to take the above on your record., Thanking You, Yours failhfhlly, For Mangalam Drugs & Organices Limited Govardhan M. Dhoot Chairman & Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com Mangalam Drugs and Organics Limited % Regd. Office : R ®u 9p 1a -m 2 2B -ui 6l 2d 6i 1ng 6, 2 03 0r d / F 6loo 3r, 2 /0 3 89 70 8P. 7 D @' M 9el 1l -o 2 2R -o 6a 2d 6, 1 N 9e 0a 9r 0 G ». CP. I N0 . : M [u 2m 42b 3a 0i M - H 4 10 90 7 20 P0 L1 C116413 fi W' O ccredited PROCEEDINGS OF THE (53RP) FIFTY THIRD ANNUAL GENERAL MEETING (AGM) _OF _MANGALAM _DRUGS AND ORGANICS LIMITED HELD ON WEDNESDAY, SEPTEMBER 23R, 2026 AT 3:00 P.M. THROUGH VIDEO CONFERENCING/ OTHER AUDIO-VISUAL MEANS. This is to inform you that the members of Mangalam Drugs and Organics Limited (“the Company”) at the 53" Annual General Meeting (“AGM”) held on Wednesday, September 23", 2026 transacted the Business as per the AGM Notice. The AGM was commenced at 03:00 P.M. Indian Standard Time (1.S.T) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) and concluded at 4:00 P.M. (including the time allowed for ¢ voting at AGM) (1.S.T) in compliance with all the applicable provisions of the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with circular dated May 3, 2020 read with circulars dated April 8, 2020, April 13, 2020, 13™ January, 2021 and May 05, 2022 (‘MCA Circulars’) and Securities and Exchange Board of India has vide its circular dated May 12, 2020 January 15, 2021 and May 13, 2022 (‘SEBI Circulars’). The Company provided remote e-voting facility at the AGM to its members in respect of the Business to be transacted at AGM. CREDENTIALS OF MEETING: Commencement Time | 03:00 P.M. 04:00P.M.(including the time allowed fore -voting at AGM 30 Conclusion Time : minutes) Daotf AcGM | Wednesday. September 23,2026 Deemed Venue of 3" Floor, Rupam Building 239, P. D'MELLO Road Mumbai AGM 400001, Maharashtra, India. Through Video Conferencing (VC) /Other Audio-Visual Means Mode (OAVM) Manner of Approval of Resolutions Through Venue Voting facility as provided by the Company Members Attended Mecting Equity Shareholders Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com Mangalam Drugs and Organics Limited Regd. Office : ®Ru 9p 1a 2m 2 B 6u 2il 6d 1in 6g 2, 03 0rd / F 6l 3oo 0r 0, /2 3 89 7 8P 7. D &'M 9el 1l -o 2 2R -o 6a 2d 6, 1 N 9e 0a 9r 0 G ». CP. I N0 . - M Lu 24m 2b 3a 0i M - H 4 10 90 7 20 P01 L. C 116413 — OMAN GA LAM DIRECTORS’ PRESENT: ;r 0. . Name of Director DIN Designation Shri Govardhan Murlidhar Dhoot 01240086 | Ex“eceuctitvie ve DDiirreeccttoorr,, ChaCih airperson and Managing Director Executive Director 2 Shri Brijmohan Murlidhar Dhoot 01046420 (Whole time Director) Shri Rakesh Kishinchand Milwani 01115469 | No“nO-nE-;i ecutiive ve -No-nN-onI-nIdn dependdeennt Director Shri Praveen Saxena 03199264 | N| oOnn-xEe cutiivve e -- InIndd ependdeennt Director 5. 3 | Shri Prabhakar Raghunath Zavar 11940187 No on- nE xecut ci uv te i ve - - InInd d epend de en nt Director Non-Executive - Independent Director and Chairperson of Audit Smt. Nidhi Shantanu Mundada 08134952 | Committee, Nomination & Remuneration Committee and Stakeholders Relationship Committee IN ATTENDANCE AND INVITEES: Name No. Designatiol | Mr. Jeevan Dalvi Chief Financial Officer (CFO) 5. | Ms. Shweta Patel Company Secretary & Compliance Officer 3. | Ms. Shreya Bhavsar Secretarial Team Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com & http://www.r angalamdrugs.com Mangalam Drugs and Organics Limited MANGALAM Regd. Office : Rupam Building, 3rd Floor, 239 P. D’Mello Road, Near G. P. O. Mumbai - 400 001 @ 91-22-62/6 613060 2/ 807807 & 91-22-62619090 e CIN : L24230MH1972PLC116413 4. | WMr a. i kJ ui lt endra Pandey and Mr. Sujoy | Representative of S. N, Nanda & Co.,(Proposed Statutory Auditor of the company) 5. Mr -. Vi Vd ih cy ha yd aha cr h ar S Somanii AP uro dp ir t4 i oe rt o or . o tf V . cS o. pS ao nm ya )n i & Co.,( Retiring Statutory 6. | Mr. Rampurawala Mohammed Rampurawala Mohammed A & Co., (Cost Auditor) Mr. L.N Joshi Represernatlvelof I},.N. Joshi & Co.,(Proposed Secretarial Auditor of the Company) g | Mr. BM Maheshwari Scrutinizer of 53'Y Annual General Meeting PROCEEDINGS IN BR a. Shri Govardhan Murlidhar Dhoot (DIN: 01240086), Chairperson and Managing Director of the Company took the chair. The meeting was virtually attended by 49 Members. The above- mentioned directors and invitees were present at the meeting. As per Section 103 of the Companies Act, 2013, the Chairman then confirmed that the requisite quorum is present and announced the formal commencement oft he meeting. b. Ms. Shweta Patel, the Company Secretary & Compliance Officer of the Company welcomed all the members at the 53 AGM and briefed the meeting on few points regarding participation in the meeting electronically. ¢. Thereafter, Company Secretary requested Shri Govardhan Murlidhar Dhoot (DIN: 01240086), Chairperson and Managing Director oft he Company to address the Shareholders. Shri Govardhan Murlidhar Dhoot (DIN: 01240086) introduced all the Directors present at the meeting along with the Auditors. Shri Govardhan Murlidhar Dhoot then delivered his speech and apprised all the Members about the current and future prospectus and Corporate Governance of the Company. d. Thereafter, Company Secretary addressed Shareholders stating that the Company had taken all the efforts feasible to enable the members to participate and vote on the items being considered in the meeting. He also briefed on general instructions to attend the meeting. €. The members were informed that pursuant to the provisions of Section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014, as amended and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had extended remote E-Voting facility in respect of all Factory : at Vapi (Gujarat) India & contactus@mangalamdrugs.com @ http://www. mangalamdrugs.com Mangalam Drugs and Organics Limited Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001. @ 91-22-62616200 / 63/0 87087 @ 91-22-62619090 e CIN : L24230MH1972PLC116413 businesses to be transacted at the 53" Annual Gene [Showing first 8,000 characters — download PDF for full document]